MCM
MDLN icon

Mengis Capital Management’s Medline Inc MDLN Stock Holding History

Mengis Capital Management’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$437K Buy
12,595
+415
+3% +$15.2K 0.07% 170
2026
Q2 		$480K Buy
+12,180
New +$491K 0.07% 173

Other funds holding MDLN

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
CAM
Clio Asset Management Charlottesville, Virginia $119M AUM 1.1% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
TA
TrueWealth Advisors Birmingham, Alabama $445M AUM 13.38% 1-Year Est. Return
FA
Fiduciary Alliance Greenville, South Carolina $1.33B AUM 15.58% 1-Year Est. Return
SWM
Sendero Wealth Management San Antonio, Texas $1B AUM 21.35% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Mengis Capital Management's MDLN Position: Q3 2026 in Review

Mengis Capital Management increased its Medline Inc (MDLN) stake by 3.4% in Q3 2026, buying an estimated $15.2K and bringing the position to 12,595 shares worth $437K. The position accounts for 0.07% of the portfolio, ranked #170.

Mengis Capital Management first reported a position in MDLN in Q2 2026 and has held it in 2 quarters since. The position peaked at $480K in Q2 2026. 19 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Mengis Capital Management held 12,595 shares of Medline Inc worth $437K as of Q3 2026.
  • Mengis Capital Management bought 415 Medline Inc shares in Q3 2026, an estimated $15.2K.
  • Medline Inc made up 0.07% of Mengis Capital Management's portfolio in Q3 2026, its #170 holding.
  • Mengis Capital Management first reported a position in Medline Inc in Q2 2026 and has held it in 2 quarters since.
  • Mengis Capital Management's Medline Inc position peaked at $480K in Q2 2026.
  • 19 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on Mengis Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.